PL1694354T3 - Sposób zapobiegania i leczenia cukrzycy za pomocą neurturyny - Google Patents
Sposób zapobiegania i leczenia cukrzycy za pomocą neurturynyInfo
- Publication number
- PL1694354T3 PL1694354T3 PL04803341T PL04803341T PL1694354T3 PL 1694354 T3 PL1694354 T3 PL 1694354T3 PL 04803341 T PL04803341 T PL 04803341T PL 04803341 T PL04803341 T PL 04803341T PL 1694354 T3 PL1694354 T3 PL 1694354T3
- Authority
- PL
- Poland
- Prior art keywords
- preventing
- neurturin
- treating diabetes
- diabetes
- administering
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/507—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Neurology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03027383 | 2003-11-27 | ||
PCT/EP2004/013534 WO2005051415A1 (en) | 2003-11-27 | 2004-11-29 | Method for preventing and treating diabetes using neurturin |
EP04803341A EP1694354B1 (en) | 2003-11-27 | 2004-11-29 | Method for preventing and treating diabetes using neurturin |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1694354T3 true PL1694354T3 (pl) | 2009-12-31 |
Family
ID=34626383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04803341T PL1694354T3 (pl) | 2003-11-27 | 2004-11-29 | Sposób zapobiegania i leczenia cukrzycy za pomocą neurturyny |
Country Status (9)
Country | Link |
---|---|
US (4) | US20080241106A1 (pl) |
EP (1) | EP1694354B1 (pl) |
JP (5) | JP4838724B2 (pl) |
AT (1) | ATE435026T1 (pl) |
DE (1) | DE602004021847D1 (pl) |
DK (1) | DK1694354T3 (pl) |
ES (1) | ES2329583T3 (pl) |
PL (1) | PL1694354T3 (pl) |
WO (1) | WO2005051415A1 (pl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050222070A1 (en) | 2002-05-29 | 2005-10-06 | Develogen Aktiengesellschaft Fuer Entwicklungsbiologische Forschung | Pancreas-specific proteins |
PL1694354T3 (pl) | 2003-11-27 | 2009-12-31 | Develogen Ag | Sposób zapobiegania i leczenia cukrzycy za pomocą neurturyny |
EP1872790A1 (en) * | 2006-06-26 | 2008-01-02 | DeveloGen Aktiengesellschaft | New formulation for increasing bioavailability of neurturin |
US8637459B2 (en) * | 2006-11-08 | 2014-01-28 | Emory University | Enhancing a population of insulin releasing cells using GFR-A1 agonists |
BRPI0819220A2 (pt) * | 2007-11-05 | 2019-02-26 | Develogen Aktiengessellschaft | proteína neurturina ou fragmento da mesma, sua composição farmacêutica e uso |
JP2011057674A (ja) | 2009-09-11 | 2011-03-24 | Omnica Gmbh | コエンザイムq−10と抗酸化剤とを含む組成物 |
US8445432B2 (en) | 2009-10-30 | 2013-05-21 | Ntf Therapeutics Inc | Neurturin molecules |
US9127083B2 (en) | 2009-10-30 | 2015-09-08 | Ntf Therapeutics, Inc. | Neurturin molecules |
AU2010313456A1 (en) * | 2009-10-30 | 2012-05-17 | Ntf Therapeutics, Inc. | Improved neurturin molecules |
US9907767B2 (en) | 2010-08-03 | 2018-03-06 | Velicept Therapeutics, Inc. | Pharmaceutical compositions and the treatment of overactive bladder |
JP6051378B2 (ja) * | 2011-05-02 | 2016-12-27 | 国立大学法人 熊本大学 | 幹細胞からインスリン産生細胞への分化誘導を促進する低分子化合物および該化合物を用いた幹細胞からインスリン産生細胞への分化誘導方法 |
WO2013063389A2 (en) * | 2011-10-26 | 2013-05-02 | University Of Louisville Research Foundation, Inc. | Methods and compositions for treating diabetes and other degenerative neuroendocrine diseases or disorders |
US9821026B2 (en) * | 2012-06-28 | 2017-11-21 | Instituto De Medicina Molecular | Use of RET agonist molecules for haematopoietic stem cell expansion protocols and transplantation therapy and a RET agonist kit |
WO2014138725A1 (en) * | 2013-03-08 | 2014-09-12 | Curators Of The University Of Missouri | Methods and compositions for the treatment and/or prevention of type 1 diabetes |
KR20170086659A (ko) | 2014-12-03 | 2017-07-26 | 벨리셉트 테라퓨틱스, 인크. | 하부 요로 증상을 위한 변형 방출형 솔라베그론을 이용한 조성물 및 방법 |
CN108290824B (zh) | 2015-10-23 | 2022-03-11 | B3Ar治疗股份有限公司 | 索拉贝隆两性离子及其应用 |
JP6960106B2 (ja) * | 2018-01-17 | 2021-11-05 | Toto株式会社 | 浴槽用枕 |
JP2022534295A (ja) * | 2019-05-30 | 2022-07-28 | イミュノルクス インターナショナル コーポレーション | ワクチン接種及び疾患治療法のための自己人工多能性幹細胞とのポックスウイルスの使用 |
WO2022162067A1 (en) * | 2021-01-30 | 2022-08-04 | Universitat Autònoma De Barcelona | Gene therapy for monogenic diabetes |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5739307A (en) | 1995-08-28 | 1998-04-14 | Washington University | Polynucleotide encoding neurturin neurotrophic factor |
US6743628B1 (en) | 1995-08-28 | 2004-06-01 | Washington University | Method of cell culture using neurturin |
US6391312B1 (en) * | 1997-01-23 | 2002-05-21 | Sumitomo Pharmaceuticals Co., Limited | Remedies for diabetes |
ES2258295T3 (es) * | 1997-02-18 | 2006-08-16 | Genentech, Inc. | Receptor de la neurturina. |
US6043221A (en) | 1997-07-30 | 2000-03-28 | Amgen Inc. | Method for preventing and treating hearing loss using a neuturin protein product |
WO2000017360A1 (en) | 1998-09-22 | 2000-03-30 | University Of Maryland, Baltimore | Cystine knot growth factor mutants |
WO2000018922A2 (en) | 1998-10-01 | 2000-04-06 | Incyte Genomics, Inc. | Human carbohydrate-associated proteins |
DK1223966T3 (da) | 1999-10-29 | 2003-08-18 | Bioph Biotech Entw Pharm Gmbh | Anvendelse af GDNF til behandling af hornhindedefekter |
AU2001236589A1 (en) | 2000-02-04 | 2001-08-14 | Aeomica, Inc. | Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes |
DE10290025T1 (de) * | 2001-04-19 | 2003-10-09 | Develogen Ag | Verfahren zur Differenzierung von Stammzellen in Insulin-produzierende Zellen |
US20050222070A1 (en) | 2002-05-29 | 2005-10-06 | Develogen Aktiengesellschaft Fuer Entwicklungsbiologische Forschung | Pancreas-specific proteins |
EP2269628A3 (en) | 2002-05-29 | 2011-04-20 | DeveloGen Aktiengesellschaft | Pancreas-specific proteins |
WO2004093804A2 (en) | 2003-04-18 | 2004-11-04 | Five Prime Therapeutics, Inc. | Human polypeptides encoded by polynucleotides and methods of their use |
PL1694354T3 (pl) | 2003-11-27 | 2009-12-31 | Develogen Ag | Sposób zapobiegania i leczenia cukrzycy za pomocą neurturyny |
EP1872790A1 (en) | 2006-06-26 | 2008-01-02 | DeveloGen Aktiengesellschaft | New formulation for increasing bioavailability of neurturin |
BRPI0819220A2 (pt) | 2007-11-05 | 2019-02-26 | Develogen Aktiengessellschaft | proteína neurturina ou fragmento da mesma, sua composição farmacêutica e uso |
-
2004
- 2004-11-29 PL PL04803341T patent/PL1694354T3/pl unknown
- 2004-11-29 EP EP04803341A patent/EP1694354B1/en not_active Not-in-force
- 2004-11-29 WO PCT/EP2004/013534 patent/WO2005051415A1/en active Application Filing
- 2004-11-29 DE DE602004021847T patent/DE602004021847D1/de active Active
- 2004-11-29 AT AT04803341T patent/ATE435026T1/de active
- 2004-11-29 US US10/580,601 patent/US20080241106A1/en not_active Abandoned
- 2004-11-29 DK DK04803341T patent/DK1694354T3/da active
- 2004-11-29 JP JP2006540406A patent/JP4838724B2/ja not_active Expired - Fee Related
- 2004-11-29 ES ES04803341T patent/ES2329583T3/es active Active
-
2011
- 2011-02-15 US US13/028,181 patent/US8399408B2/en not_active Expired - Fee Related
- 2011-07-11 JP JP2011152853A patent/JP2012001546A/ja active Pending
- 2011-07-21 JP JP2011159556A patent/JP5647577B2/ja not_active Expired - Fee Related
-
2013
- 2013-02-15 US US13/769,011 patent/US8772233B2/en not_active Expired - Fee Related
-
2014
- 2014-01-15 JP JP2014005056A patent/JP2014074066A/ja active Pending
- 2014-05-27 US US14/287,863 patent/US20140274897A1/en not_active Abandoned
-
2015
- 2015-09-24 JP JP2015186708A patent/JP2016000759A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2016000759A (ja) | 2016-01-07 |
DE602004021847D1 (de) | 2009-08-13 |
US8399408B2 (en) | 2013-03-19 |
US20110256113A1 (en) | 2011-10-20 |
US8772233B2 (en) | 2014-07-08 |
US20130150293A1 (en) | 2013-06-13 |
JP2007512290A (ja) | 2007-05-17 |
JP2014074066A (ja) | 2014-04-24 |
JP2012001546A (ja) | 2012-01-05 |
WO2005051415A1 (en) | 2005-06-09 |
JP4838724B2 (ja) | 2011-12-14 |
ATE435026T1 (de) | 2009-07-15 |
DK1694354T3 (da) | 2009-10-26 |
ES2329583T3 (es) | 2009-11-27 |
EP1694354B1 (en) | 2009-07-01 |
JP2011251986A (ja) | 2011-12-15 |
US20140274897A1 (en) | 2014-09-18 |
JP5647577B2 (ja) | 2015-01-07 |
US20080241106A1 (en) | 2008-10-02 |
EP1694354A1 (en) | 2006-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1694354T3 (pl) | Sposób zapobiegania i leczenia cukrzycy za pomocą neurturyny | |
WO2003088923A3 (en) | Methods of treating ileus | |
WO2003096983A3 (en) | Method of treating dyslipidemic disorders | |
WO2005086661A3 (en) | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders | |
WO2006073973A3 (en) | Novel benzylamine derivatives as cetp inhibitors | |
RS20060320A (en) | Substituted indazole-o-glucosides | |
IL160319A0 (en) | Compositions and method of treating diabetes | |
WO2005086656A3 (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
MY142777A (en) | Substituted indole-o-glucosides | |
UA87991C2 (en) | Substituted indole-o-glucosides | |
WO2003096977A3 (en) | Methods of treating hepatitis | |
WO2004014352A3 (en) | Methods for treating carbonic anhydrase mediated disorders | |
TW200604179A (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
WO2005046603A3 (en) | Pyridine compounds | |
BR0114054A (pt) | Método para tratar alergias usando pirazóis substituìdos | |
MX2007002470A (es) | Fenilaminotiazoles sustituidos y su uso. | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
WO2006042745A3 (de) | Chemisch modifizierte iapp - peptidanaloga | |
WO2008011478A3 (en) | Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds | |
AU2016204334A1 (en) | Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds | |
MXPA03010322A (es) | PROCEDIMIENTO PARA LA PREPARACIoN DE POLIISOCIANATOS. | |
WO2005112923A3 (en) | 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes | |
AU7918500A (en) | Substituted diazepanes | |
WO2005051331A3 (en) | Chaperone-based therapy for niemann-pick disease | |
AU2003215190A1 (en) | Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. |